Workflow
TreeHouse Foods, Inc. Reports Second Quarter 2025 Results
Prnewswire· 2025-07-31 18:55
财务表现 - 2025年第二季度净销售额达7.98亿美元,同比增长1.2%,主要得益于私人品牌茶叶业务收购、商品通胀恢复性定价以及分销渠道拓展[3] - 调整后EBITDA为7330万美元,超出指引区间上限,同比增加270万美元,供应链节约措施和Harris Tea收购带来积极影响[8] - 毛利率提升1.1个百分点至17.4%,保险理赔1310万美元及供应链优化措施是主要驱动因素[4] 运营动态 - 营业费用减少2040万美元至1.119亿美元,主要因2024年RTD饮料资产组1930万美元的非现金减值费用不再发生[5] - 公司退出即饮饮料业务(RTD)导致销售额下降1%,同时冷冻烤盘产品自愿召回影响销售额1.2%[3] - 资本支出维持1.25亿美元预期,自由现金流目标仍为至少1.3亿美元[12] 战略方向 - 管理层强调将持续执行既定计划,通过提升运营效率驱动利润率改善和现金流增长[2] - 私人品牌战略被重申具有吸引力,能为客户和消费者提供价值,同时保持对外部环境的抗风险能力[2] - 供应链优化措施全年预计带来显著成本节约,Harris Tea收购业务已产生增值效应[8] 财务指引 - 2025全年调整后净销售额预期区间33.6-34.15亿美元,同比变化-0.5%至+1%[12] - 第三季度调整后净销售额指引8.4-8.7亿美元,中点同比持平,其中定价因素预计带来4%的积极影响[25] - 全年调整后EBITDA目标维持3.45-3.75亿美元区间,净利息支出预期8000-9000万美元[12]
Kimco Realty® Announces Second Quarter 2025 Results
Globenewswire· 2025-07-31 18:50
– Increases 2025 Outlook on Solid Growth in Net Income and FFO – – Same Property NOI Increased 3.1% – – Small Shop Occupancy Reaches Record High – JERICHO, N.Y., July 31, 2025 (GLOBE NEWSWIRE) -- Kimco Realty® (NYSE: KIM), a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States, today reported results for the second quarter ended June 30, 2025. For the three months ended June 30, 2025 and ...
Dillard's and Pandora Celebrate Pandora's 100th Dillard's Location
GlobeNewswire News Room· 2025-07-31 18:50
合作里程碑 - Dillard's与全球最大珠宝品牌Pandora共同庆祝第100家Pandora专柜入驻 该专柜位于密苏里州斯普林菲尔德Battlefield Mall新店[1][3] - 合作始于2024年秋季 最初在15家Dillard's门店试点 后迅速扩展至99家 最终达成百家门店规模[3] 合作成效与战略 - Dillard's高管指出 Pandora的创新设计与高品质工艺完美契合公司客户对独特优质产品的需求 客户反响远超预期[4] - Pandora北美总经理表示 通过Dillard's渠道触达了新老客户群体 强化了品牌真实购物体验 未来将持续推动共同增长[4] - 双方合作目标是为珠宝及时尚爱好者创造难忘的消费体验[5] 公司背景 **Pandora** - 全球最大珠宝品牌 产品覆盖100多个国家 销售网点达6800个 含2700家概念店[6] - 2024年营收317亿丹麦克朗(42亿欧元) 全球员工3.7万人 采用100%回收金银材料[7] - 总部位于丹麦哥本哈根 纳斯达克上市公司 承诺2030年前将价值链碳排放减半[7] **Dillard's** - 1938年创立 现为美国大型时尚零售商 运营272家门店(含28家折扣中心) 覆盖30个州[8] - 主营高端时尚服饰、美妆及家居产品 强调精选品牌组合与客户至上的服务理念[8]
Dillard’s and Pandora Celebrate Pandora’s 100th Dillard’s Location
Globenewswire· 2025-07-31 18:50
Pandora @ Dillard's Pandora is now available in 100 Dillard's locations across the nation. Pandora @ Dillard's Pandora is now available in 100 Dillard's locations across the nation. Pandora @ Dillard's Pandora is now available in 100 Dillard's locations across the nation. Pandora @ Dillard's Pandora is now available in 100 Dillard's locations across the nation. LITTLE ROCK, Ark., July 31, 2025 (GLOBE NEWSWIRE) -- Dillard’s, Inc. (“Dillard’s” or “the Company”) (NYSE: DDS) and Pandora, the ...
MGIC Investment: Solid Q2 With Minimal Losses Persisting
Seeking Alpha· 2025-07-31 18:45
Shares of MGIC Investment Corp ( MTG ) have been a modest performer over the past year, gaining 2%. After a strong run, the stock has pulled back over the past month as concerns have intensified around a slowing in theOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a question for an article, just let me know!Analyst’s Disclosur ...
Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
CNBC· 2025-07-31 18:45
核心观点 - 礼来公司的糖尿病药物Mounjaro在后期试验中显示出心脏健康益处,直接与公司老牌糖尿病药物Trulicity进行比较 [1] - Mounjaro达到研究主要目标,证明其在治疗2型糖尿病和心血管疾病患者方面不劣于Trulicity [2] - 尽管结果未达到部分分析师认为优于Trulicity的基准,但公司认为新数据支持Mounjaro成为2型糖尿病患者的首选药物 [3] - Mounjaro在近5年研究中降低心血管死亡、心脏病发作或中风风险8%,这是迄今为止关于其活性成分tirzepatide最大规模的试验,涉及超过13,000人 [4] - Mounjaro显示出比Trulicity更全面的益处,包括全因死亡率降低16%和更好的肾脏保护作用 [5] 临床试验结果 - Mounjaro与Trulicity相比,全因死亡率差异显著,临床意义重大 [6] - 数据量化了两种药物之间的差异,有助于医疗提供者和患者共同决策最佳治疗方案 [7] - 专家称Mounjaro在试验中是"赢家",唯一缺点是比Trulicity有轻微更多的副作用 [8] - 完整结果将在欧洲医学会议上展示并于秋季发表在同行评审期刊上 [9] 市场影响 - Trulicity作为礼来畅销药物面临2027年专利到期,可能进一步提升Mounjaro在糖尿病市场的地位 [3] - 结果公布时礼来股价在盘前交易中下跌4% [2] - 礼来计划年底前向全球监管机构提交心脏健康数据,可能导致2026年获批用于此目的 [11] - 礼来巩固其在减肥和糖尿病药物蓬勃发展的市场中对诺和诺德的领先地位 [10] 药物特性比较 - Mounjaro在心血管指标、降低体重和A1C(血糖水平测量)方面比Trulicity有更大改善 [16] - 两种药物的安全性数据与既往观察一致,最常见的不良事件是胃肠道相关,严重程度一般为轻度至中度 [16] - 活性成分tirzepatide因其"强大特性"已在市场上"获得显著采用" [15] 适用范围 - 任何批准不适用于礼来减肥药物Zepbound,尽管它与Mounjaro具有相同活性成分,但专门用于肥胖而非糖尿病患者 [12] - 公司正在研究Zepbound对肥胖和心血管疾病患者的心血管益处,三期试验预计2027年完成 [12] - 约30%的2型糖尿病患者同时患有心血管疾病 [13]
Ares Strategic Mining Launches Gallium Recovery Program with Iowa State University and Ames National Laboratory
Thenewswire· 2025-07-31 18:45
 Vancouver, B.C., July 31, 2025 – TheNewswire - Ares Strategic Mining Inc. (CSE: ARS) (OTC: ARSMF) (FRA: N8I1) is pleased to announce the initiation of a collaborative research program with Iowa State University (ISU) and the Ames National Laboratory, aimed at unlocking the potential of gallium extraction from the Company’s fluorspar ores sourced from its Spor Mountain project in Utah. Gallium, a U.S.-designated critical mineral, is essential to the global electronics, photonics, and clean energy industrie ...
Brazil's Grupo Petrópolis Uses Descartes Routing Solution to Optimize Nationwide Beverage Distribution
Globenewswire· 2025-07-31 18:45
SÃO PAULO and ATLANTA, July 31, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Brazil’s Grupo Petrópolis is using Descartes’ routing and fleet management solution to enhance its nationwide beverage distribution operations using approximately 2,900 vehicles. The Descartes solution helped Grupo Petrópolis achieve an on-time delivery rate of 98%, reduce overtime hours by 9% and decrease fuel consu ...
Costamare Inc. Reports Results for the Second Quarter and Six-Month Period Ended June 30, 2025
Globenewswire· 2025-07-31 18:45
MONACO, July 31, 2025 (GLOBE NEWSWIRE) -- Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results for the second quarter and six-month period ended June 30, 2025. Discontinued operations as a result of Costamare Bulkers Holdings Limited Spin-Off The financial results for the three- and six-month periods ended June 30, 2025, reflect the spin-off of Costamare’s dry bulk business (consisting of Costamare’s dry bulk owned fleet and its dry bulk operating platform, C ...
XPO Reports Second Quarter 2025 Results
Globenewswire· 2025-07-31 18:45
GREENWICH, Conn., July 31, 2025 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO) today announced its financial results for the second quarter 2025. The company reported diluted earnings per share of $0.89, compared with $1.25 for the same period in 2024, and adjusted diluted earnings per share of $1.05, compared with $1.12 for the same period in 2024. Second Quarter 2025 Summary Results Three Months Ended June 30, Revenue Operatin ...